LONDON, April 10, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Wednesday, April 09, 2014, with the NASDAQ
Composite closing at 4,183.90, up 1.72%, the Dow Jones Industrial
Average ending the session at 16,437.18, up 1.11%, and the S&P
500 edging 1.09% higher to finish the trading session at 1,872.18.
The session saw a positive impact from Information Technology,
Health Care and Materials sectors along with a drag from Utilities
and Telecommunication Services sectors. A number of stocks saw
large movements, including Science Applications International Corp.
(NYSE: SAIC), Maxwell Technologies Inc. (NASDAQ: MXWL), Albany
Molecular Research Inc. (NASDAQ: AMRI) and Demandware Inc. (NYSE:
DWRE). Free technical research on SAIC, MXWL, AMRI and DWRE can be
downloaded upon signing up at:
http://www.investor-edge.com/1023-register
Shares in Science Applications International Corp. edged 8.54%
higher, finishing Wednesday's session at $39.03. The stock fluctuated between $36.32 and $39.34 during the session with a
trading volume of 1.02 million shares as compared with its three
months average volume of 0.25 million shares. Shares in Science
Applications International Corp. have rallied 11.61% in the
previous three trading sessions, 9.51% in the last three months,
and 18.02% on YTD basis. The S&P 500 Information Technology
Sector Index mapped a gain of 1.56% during the trading session,
while the same has declined 0.16% in the last one month. The
company's stock is trading above its 50-day moving average of
$36.73 and at a PE ratio of 12.17.
Furthermore, the company's stock has a Relative Strength Index
(RSI) of 46.66. Sign up today to read free research on SAIC at:
http://www.investor-edge.com/1023-SAIC-10Apr2014.pdf
On Wednesday, Maxwell Technologies Inc.'s stock ended the session
at $14.36, up 9.45%. A total of 0.99
million shares were traded as compared with its three months
average volume of 0.77 million shares. During the session, the
stock traded between $12.88 and
$14.51. Maxwell Technologies Inc.'s shares have surged 7.97%
in the past three trading sessions, 93.53% in the previous three
months, and 84.81% on YTD basis. The S&P 500 Information
Technology Sector Index mapped a gain of 1.56% during the trading
session and the same has advanced 3.33% in the last three months.
The stock is trading above its 50-day and 200-day moving averages
of $11.35 and $8.96, respectively. Further, the company's stock
has an RSI of 51.57 and is trading at a PE ratio of 65.27. Sign up
today to read free research on MXWL at:
http://www.investor-edge.com/1023-MXWL-10Apr2014.pdf
Shares in Albany Molecular Research Inc. finished Wednesday's
session at $16.89, up 10.54%. A total
of 0.98 million shares were traded which is above its three months
average volume of 0.63 million shares. The stock vacillated between
$15.74 and $17.09 during the session
and traded at a PE ratio of 24.94. Albany Molecular Research Inc.'s
shares have advanced 8.13% in the last one month, 59.34% in the
previous three months, and 67.56% on YTD basis. The S&P 500
Health Care Sector Index mapped a gain of 2.11% during the trading
session, and the same has advanced 2.86% in the last three months.
Additionally, the company's stock has an RSI of 38.51 and is
trading above its 50-day and 200-day moving averages of
$15.19 and $12.80, respectively. Sign up today to read free
research on AMRI at:
http://www.investor-edge.com/1023-AMRI-10Apr2014.pdf
Demandware Inc.'s stock closed Wednesday's session at $56.93, up 7.74%, after oscillating between
$53.55 and $57.08. A total of 0.75
million shares were traded, which is above its three months average
volume of 0.49 million shares. Shares in Demandware Inc. have
gained 0.73% in the previous three trading sessions, while the same
has lost 25.36% in the last one month and 11.21% on YTD basis. The
S&P 500 Information Technology Sector Index mapped a gain of
1.56% during the trading session and 1.65% in the past three
trading sessions. Moreover, the company's stock has an RSI of 26.79
and is trading above its 200-day moving average of $56.29. Sign up today to read free research on
DWRE at:
http://www.investor-edge.com/1023-DWRE-10Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Namrata
Maheshwari, a CFA charterholder. However, we are only human
and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Namrata Maheshwari, CFA, has only
reviewed the information provided by Investor-edge in this article
or report according to the Procedures outlined by Investor-edge.
Investor-edge is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the
articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge